Centrient Pharmaceuticals
Valerio di Caprio has a diverse work experience spanning across different companies and roles. Valerio began their career as an intern at Sirti in 2004. In 2009, they joined Ernst & Young as a Staff member before transitioning to Bain & Company, where they held various positions including Associate Consultant, Senior Associate Consultant, Consultant, Case Team Leader, and Senior Manager.
In 2016, Valerio joined Centrient Pharmaceuticals as the Global Strategy Director, and later served as the Chief Strategy, M&A, and Marketing Officer. Valerio also took on additional responsibilities as the Marketing Director for Asia Pacific, Middle East, and Africa on an interim basis. In 2021, Valerio became the Franchise Director for Semi Synthetic Penicillins and Pen, and in 2022, they assumed the role of Global VP for Semi Synthetic Penicillins and Pen, responsible for P&L.
Valerio di Caprio completed their Bilingual IB Diploma in Physics and Economics at Le Rosey from 1998 to 2003. Valerio then pursued a MSc/Laurea Specialistica in Management Engineering/Ingegneria Gestionale from Politecnico di Milano from 2003 to 2008.
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.